An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer.
针对 GPR56 的抗体药物偶联物在结直肠癌的临床前模型中显示出疗效
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02192-3
Jacob Joan, Francisco Liezl E, Chatterjee Treena, Liang Zhengdong, Subramanian Shraddha, Liu Qingyun J, Rowe Julie H, Carmon Kendra S
